Researchers have identified a set of potential immunodominant epitopes from the SARS-CoV-2 proteome. These epitopes are capable of generating both antibody- and cell-mediated immune responses. The findings of this work may thus contribute to developing a peptide vaccine against SARS-CoV-2 infections which can stop the COVID-19 outbreak and future pandemics caused by coronaviruses.
- New technology allows scientists first glimpse of intricate details of Little Foot’s life
- Tissue, scaffold technologies provide new options for breast cancer, other diseases
- High fat diets may over-activate destructive heart disease protein
- A materials science approach to combating coronavirus
- New study proposes a low cost, high efficiency mask design